Chemical Biology Advances in Protein Conformational Diseases
This special issue belongs to the section "Biochemistry".
Special Issue Information
Dear Colleagues,
Protein Conformational Diseases (PCD) constitute a major global challenge due to their profound economic, social, and ethical impact. This burden is particularly evident in disorders that originate early in life, including obesity, diabetes mellitus, metabolic syndrome, Alzheimer’s disease, and cancer. Despite their clinical heterogeneity, these conditions share a common molecular hallmark: they are diagnosed at advanced stages, when up to 50% of the target organ has already undergone irreversible damage.
From a chemical biology perspective, PCD represent a convergence point where molecular structure, chemical interactions, and biological function intersect to dictate health and disease. In this Issue, we advocate for an integrated and mechanistic view of PCD, treating them not as isolated clinical entities but as chemically driven biological processes with systemic and societal consequences.
We focus on deciphering the chemical and biophysical principles governing protein misfolding, aggregation, oligomerization, and fibrillation—molecular events that initiate and sustain pathological cascades. Chemical biology provides the conceptual and methodological framework to interrogate these processes with molecular precision, enabling the design of chemical probes, structure-informed biomarkers, and novel molecules that function simultaneously as diagnostic tools and therapeutic targets.
A key objective of this Issue is to encourage the development and implementation of early, chemistry-enabled diagnostic strategies that allow large-scale population screening and the stratification of individuals at risk prior to the onset of irreversible pathology. By shifting the paradigm from late-stage clinical intervention to early molecular detection, chemical biology has the potential to redefine disease trajectories and outcomes.
Beyond their molecular complexity, PCD pose a profound ethical and social responsibility. Delayed diagnosis and limited access to early detection technologies exacerbate health inequities and amplify long-term societal costs. Addressing these challenges requires not only chemical and biological innovation but also a commitment to translational impact, public health relevance, and equitable deployment of molecular technologies.
Finally, this Issue will highlight the identification of novel chemically tractable targets and the development of innovative therapeutic strategies rooted in chemical biology, with the ultimate goal of reshaping prevention, diagnosis, and treatment paradigms for PCD.
Dr. Myriam M. Altamirano-Bustamante
Dr. Nelly Altamirano-Bustamante
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- protein conformational diseases
- misfolding and diseases
- protein folding and diseases
- amyloid proteins and diseases
- diabetes
- obesity
- metabolic syndrome
- Alzheimer diseases
- cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

